OPRX

$9.663.54%0.33

Optimizerx Corp (OPRX)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$9.33

Offen:

$9.49

24-Stunden-Volumen:

26,956

Relatives Volumen:

0.22

Marktkapitalisierung:

$181.96M

Einnahmen:

$107.35M

Nettoeinkommen (Verlust:

$6.84M

KGV:

27.35

EPS:

$0.3532

Netto-Cashflow:

$14.64M

1W Leistung:

+3.87%

1M Leistung:

+12.72%

6M Leistung:

+42.69%

1Y Leistung:

-48.56%

1-Tages-Spanne:

$9.48$9.82

1-Wochen-Bereich:

$9.00$9.64

52-Wochen-Spanne:

$4.54$21.09

Optimizerx Corp Aktie (OPRX) Unternehmensprofil

Firmenname

Optimizerx Corp

Sektor

Healthcare

Branche

Health Information Services

Telefon

248-651-6558

Adresse

260 CHARLES STREET, WALTHAM, MI, USA

Mitarbeiter

133

@OpRxTweets

Nächster Verdiensttermin

2026-11-11

Neueste SEC-Einreichungen

SEC

OPRX-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Optimizerx Corp Aktie (OPRX) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-09-29	Resumed	B. Riley Securities	Buy
2025-01-08	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2024-12-20	Eingeleitet	Stephens	Equal-Weight
2024-07-25	Resumed	B. Riley Securities	Buy
2024-04-04	Eingeleitet	JMP Securities	Mkt Outperform
2024-01-03	Eingeleitet	Barclays	Equal Weight
2023-02-02	Resumed	B. Riley Securities	Buy
2022-11-01	Eingeleitet	Stifel	Buy
2022-07-15	Eingeleitet	SVB Leerink	Outperform
2021-10-18	Resumed	B. Riley Securities	Buy
2021-04-13	Eingeleitet	RBC Capital Mkts	Outperform
2019-01-03	Eingeleitet	William Blair	Outperform

Finanzdaten der Optimizerx Corp-Aktie (OPRX)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	109.43	92.13	71.52	62.45	61.29
Cost of revenue USD (M)	35.83	32.75	28.62	23.48	25.65
Gross profit USD (M)	73.60	59.38	42.90	38.97	35.64
Research and development USD (M)	0.00	-	-	-	-
Operating expenses USD (M)	61.90	73.08	69.30	51.26	35.28
Operating income USD (M)	11.69	-13.71	-26.40	-12.29	0.36
Income before tax USD (M)	6.95	-19.39	71.52	-11.44	0.38
Income tax expense USD (M)	1.82	0.73	-7.60	-	-
Net income USD (M)	5.13	-20.11	-17.57	-11.44	0.38
Basic EPS USD/shares	0.28	-1.10	-1.03	-0.64	0.02
Diluted EPS USD/shares	0.27	-1.10	-1.03	-0.64	0.02
Basic weighted shares shares (M)	18.56	18.29	17.12	17.78	17.23
Diluted weighted shares shares (M)	19.00	18.29	17.12	17.78	17.69
Selling, general and administrative USD (M)	-	-	-	33.49	-

Optimizerx Corp-Aktie (OPRX) Insiderhandel

Stelmakh EdwardDec 19 '25
Chief Finance & Strat Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
5,237
Wert ($)
0
#Aktien Gesamt
128,218
Stelmakh EdwardDec 19 '25
Chief Finance & Strat Officer
Transaktion
Sale
Kosten
$13.51
#Aktien
1,388
Wert ($)
18,752
#Aktien Gesamt
126,830
Silvestro Stephen LDec 19 '25
Chief Executive Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
6,546
Wert ($)
0
#Aktien Gesamt
195,462
Odence-Ford MarionDec 19 '25
Chief Legal & Admin Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
3,928
Wert ($)
0
#Aktien Gesamt
94,526
Besch DougDec 19 '25
Chief Product & Tech Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
1,964
Wert ($)
0
#Aktien Gesamt
71,536
Silvestro Stephen LOct 03 '25
Chief Executive Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
6,649
Wert ($)
0
#Aktien Gesamt
190,536
Stelmakh EdwardOct 03 '25
Chief Finance & Strat Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
16,623
Wert ($)
0
#Aktien Gesamt
127,387
Besch DougOct 03 '25
Chief Product & Tech Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
3,325
Wert ($)
0
#Aktien Gesamt
70,555
Silvestro Stephen LOct 03 '25
Chief Executive Officer
Transaktion
Sale
Kosten
$18.75
#Aktien
1,620
Wert ($)
30,375
#Aktien Gesamt
188,916
Odence-Ford MarionOct 03 '25
Chief Legal & Admin Officer
Transaktion
Option Exercise
Kosten
$0.00
#Aktien
6,649
Wert ($)
0
#Aktien Gesamt
92,550

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Stelmakh Edward	Chief Finance & Strat Officer	Dec 19 '25	Option Exercise	$0.00	5,237	0	128,218
Stelmakh Edward	Chief Finance & Strat Officer	Dec 19 '25	Sale	$13.51	1,388	18,752	126,830
Silvestro Stephen L	Chief Executive Officer	Dec 19 '25	Option Exercise	$0.00	6,546	0	195,462
Odence-Ford Marion	Chief Legal & Admin Officer	Dec 19 '25	Option Exercise	$0.00	3,928	0	94,526
Besch Doug	Chief Product & Tech Officer	Dec 19 '25	Option Exercise	$0.00	1,964	0	71,536
Silvestro Stephen L	Chief Executive Officer	Oct 03 '25	Option Exercise	$0.00	6,649	0	190,536
Stelmakh Edward	Chief Finance & Strat Officer	Oct 03 '25	Option Exercise	$0.00	16,623	0	127,387
Besch Doug	Chief Product & Tech Officer	Oct 03 '25	Option Exercise	$0.00	3,325	0	70,555
Silvestro Stephen L	Chief Executive Officer	Oct 03 '25	Sale	$18.75	1,620	30,375	188,916
Odence-Ford Marion	Chief Legal & Admin Officer	Oct 03 '25	Option Exercise	$0.00	6,649	0	92,550

Optimizerx Corp Aktie (OPRX) Neueste Nachrichten

Oct 21, 2026

One manager reports sole voting power over 1.32M OptimizeRx (OPRX) shares held by clients. - Stock Titan

Oct 21, 2026

Oct 02, 2026

Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com Canada

Oct 02, 2026

Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com UK

Oct 02, 2026

Stock vesting triggers tax withholding at OptimizeRx (OPRX): 414 shares at $8.39 each. - Stock Titan

Oct 02, 2026

Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com Nigeria

Oct 02, 2026

Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com India

Oct 02, 2026

Sep 23, 2026

Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars? - Zacks Investment Research

Sep 23, 2026

Sep 22, 2026

OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath - Stock Titan

Sep 22, 2026

Sep 20, 2026

OptimizeRx Corporation - Common Stock (Nasdaq:OPRX) Detailed Stock Data - The Chronicle-Journal

Sep 18, 2026

Sep 17, 2026

OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.com.au

Sep 17, 2026

Sep 14, 2026

One prompt now builds patient and doctor audiences. OptimizeRx expanded the tool. - Stock Titan

Sep 14, 2026

Sep 08, 2026

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference - marketscreener.com

Sep 08, 2026

A 10th annual growth conference is set for New York, with OptimizeRx taking part. - Stock Titan

Sep 08, 2026

Sep 04, 2026

OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.ca

Sep 04, 2026

Sep 02, 2026

OptimizeRx (OPRX) insider stock withheld for taxes - Stock Titan

Sep 02, 2026

OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com Canada

Sep 02, 2026

OptimizeRx appoints Troy Sarich as company advisor - investing.com

Sep 02, 2026

OptimizeRx Appoints Former Johnson & Johnson Executive Troy Sarich as Company Advisor - Quiver Quantitative

Sep 02, 2026

OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com UK

Sep 02, 2026

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor - Yahoo Finance UK

Sep 02, 2026

Aug 26, 2026

OptimizeRx Corp. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com

Aug 26, 2026

Aug 24, 2026

OptimizeRx (NASDAQ: OPRX) COO keeps 25,187 shares after RSU tax withholding - Stock Titan

Aug 24, 2026

OptimizeRx (OPRX) records insider share trade - Stock Titan

Aug 24, 2026

OptimizeRx (NASDAQ: OPRX) insider logs new stock trade - Stock Titan

Aug 24, 2026

OptimizeRx (NASDAQ: OPRX) reports new insider share transaction - stocktitan.net

Aug 24, 2026

Aug 23, 2026

OPRX | OptimizeRx Corporation Common Stock Financials - Revenue Breakdown - Quiver Quantitative

Aug 23, 2026

Aug 19, 2026

OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript - AOL.com

Aug 19, 2026

OptimizeRx (OPRX) EPS and Revenue: Profit Per Share Clears Its Benchmark in the Current Update; Closing Move - vinanet.vn

Aug 19, 2026